NEW YORK, Aug. 13 (GenomeWeb News) –  Physiome Sciences of Princeton, NJ, today announced that it will acquire Predix Pharmaceuticals of Woburn, Mass.

Physiome will acquire Predix in exchange for 30 percent of the combined equity of the two firms.  The combined entity will will be headquartered in Woburn, Mass., and will be named Predix Pharmaceuticals. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.